Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
- DOI
- 10.1055/a-1880-0087
- Published
- 2022-07-12
- Container
- Geburtshilfe und Frauenheilkunde
- Publisher
- Georg Thieme Verlag KG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1055/a-1880-0087,
title = {Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT},
author = {Tobias Engler and Peter A. Fasching and Diana Lüftner and Andreas D. Hartkopf and Volkmar Müller and Hans-Christian Kolberg and Peyman Hadji and Hans Tesch and Lothar Häberle and Johannes Ettl and Markus Wallwiener and Matthias W. Beckmann and Alexander Hein and Erik Belleville and Sabrina Uhrig and Pauline Wimberger and Carsten Hielscher and Christian M. Kurbacher and Rachel Wuerstlein and Michael Untch and Florin-Andrei Taran and Hans-Martin Enzinger and Petra Krabisch and Manfred Welslau and Michael Maasberg and Dirk Hempel and Michael P. Lux and Laura L. Michel and Wolfgang Janni and Diethelm Wallwiener and Sara Y. Brucker and Tanja N. Fehm and Andreas Schneeweiss},
year = {2022},
journal = {Geburtshilfe und Frauenheilkunde},
doi = {10.1055/a-1880-0087},
url = {https://doi.org/10.1055/a-1880-0087}
}RIS
TY - JOUR TI - Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT AU - Tobias Engler AU - Peter A. Fasching AU - Diana Lüftner AU - Andreas D. Hartkopf AU - Volkmar Müller AU - Hans-Christian Kolberg AU - Peyman Hadji AU - Hans Tesch AU - Lothar Häberle AU - Johannes Ettl AU - Markus Wallwiener AU - Matthias W. Beckmann AU - Alexander Hein AU - Erik Belleville AU - Sabrina Uhrig AU - Pauline Wimberger AU - Carsten Hielscher AU - Christian M. Kurbacher AU - Rachel Wuerstlein AU - Michael Untch AU - Florin-Andrei Taran AU - Hans-Martin Enzinger AU - Petra Krabisch AU - Manfred Welslau AU - Michael Maasberg AU - Dirk Hempel AU - Michael P. Lux AU - Laura L. Michel AU - Wolfgang Janni AU - Diethelm Wallwiener AU - Sara Y. Brucker AU - Tanja N. Fehm AU - Andreas Schneeweiss PY - 2022 JO - Geburtshilfe und Frauenheilkunde DO - 10.1055/a-1880-0087 UR - https://doi.org/10.1055/a-1880-0087 ER -
APA
Engler, T., Fasching, P. A., Lüftner, D., Hartkopf, A. D., Müller, V., Kolberg, H., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Wallwiener, M., Beckmann, M. W., Hein, A., Belleville, E., Uhrig, S., Wimberger, P., Hielscher, C., Kurbacher, C. M., Wuerstlein, R., Untch, M., Taran, F., Enzinger, H., Krabisch, P., Welslau, M., Maasberg, M., Hempel, D., Lux, M. P., Michel, L. L., Janni, W., Wallwiener, D., Brucker, S. Y., Fehm, T. N., & Schneeweiss, A. (2022). Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/a-1880-0087
Source records
- crossref · retrieved 2026-09-25T15:31:59.217Z